Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.
about
Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysisThe anti-leukemic Bruton's tyrosine kinase inhibitor alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl) propenamide (LFM-A13) prevents fatal thromboembolismPreference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision makingShould aspirin be continued in patients started on warfarin?Optimising stroke prevention in non-valvular atrial fibrillationStudy of the Efficacy, Safety and Tolerability of Low-Molecular-Weight Heparin vs. Unfractionated Heparin as Bridging Therapy in Patients with Embolic Stroke due to Atrial Fibrillation.Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Physician compliance with outpatient oral anticoagulant guidelines in Auvergne, France.Determination of the clinical importance of study results.Development of a decision aid for atrial fibrillation who are considering antithrombotic therapyRetinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulantsPrimary Care Atrial Fibrillation Service: outcomes from consultant-led anticoagulation assessment clinics in the primary care setting in the UKClinical potential of targeting Bruton's tyrosine kinase.Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more.Atrial fibrillation in older patients-reducing stroke risk is not only about anticoagulation.Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.Atrial fibrillation post cardiac bypass surgery.Effects of anticoagulation provider continuity on time in therapeutic range for warfarin patients.Pitfalls in meta-analyses on adverse events reported from clinical trials.Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.Warfarin-associated bleeding complication saved life.Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate presEffectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.Effect of pre-adsorbed proteins on attachment, proliferation, and function of endothelial cells.The use of oral anticoagulants (warfarin) in older people. American Geriatrics Society guideline.Prescribing patterns and outcomes of enoxaparin for anticoagulation of atrial fibrillation.Pathways to poor anticoagulation control.Improved anticoagulant control in patients using home international normalized ratio testing and decision support provided through the Internet.Continuation of Aspirin Therapy before Cataract Surgery with Different Incisions: Safe or Not?Testing strategies for diagnosing lupus anticoagulant: Decision analysisAntiplatelet therapy for preventing stroke in people with atrial fibrillation
P2860
Q28081598-0AA3FE84-3BDD-420B-91B7-C3B4EEE62D50Q28165729-F1C503D1-CE7A-497E-AE51-F8DFD6D98706Q28191848-F6E9542A-0F83-4D54-AB45-9ECD2A70ABE3Q28199065-588DD22C-B167-4A99-BF54-33E2C247F1A6Q28200609-2F284741-73A0-4632-A5ED-F6672D971C1DQ33433817-0AB0328F-F973-4F76-AD5C-8AA45301DF36Q34252907-7D19925C-12D4-4219-BF93-71CEC45729EDQ34742633-25251C2C-527C-48C8-A283-81B532CEF362Q34743117-EC268B54-1927-4397-9C05-BD222FD2D69AQ34746642-18FD200F-CFFC-4A94-8054-636D77B77BFCQ35226948-70DA0857-A28A-4021-83F8-04CB28387BBBQ36374086-373E7D77-BCE2-4D0C-8EE0-05E1B0A63014Q37094690-AC3B333E-6CC7-4F5D-AA64-A8D3A217BD92Q37233377-47AB853E-4016-4FAE-A393-5BFE3F511112Q37459637-F591EC2A-F29F-417E-A834-78164E7D025CQ37730309-4996CC1A-A136-4C6C-BBAF-017266C0DA90Q38119239-F986DF2E-94EE-4F17-8013-B0EDC61E5E8DQ38809948-D06D39B2-868C-4D6C-9CF2-6AD4D2C39241Q39715445-09065CFB-307C-4F9D-B08A-936AD544FBAFQ41552749-FAFC35A6-0371-4376-9AF4-40A35241AB63Q42168389-E761406B-E855-4ACF-93F8-0E15B5DA6FCEQ42676634-787DCD3A-9CE2-4323-9FA8-E7169C02BF34Q42676674-EA299BB8-FEA2-43A4-A777-9365F0CD0D2BQ44027655-90C0D86F-3334-4ADD-AA3A-E41C92BEF098Q44091776-034C024F-95C2-4BB0-A84D-5BA39E4404D3Q44437063-D383D290-2616-437F-BF79-7863432AF703Q44607030-A5B0902B-6BCC-411D-94B2-D462B4A0F34EQ53172850-7C7539AE-FA75-4E8F-BE11-65B92DBFCCF3Q54942357-952B0920-84C4-4B91-A748-4EF3A51BDDC3Q58004012-C517A1E4-7AB1-4E98-BD77-7FD6E177866AQ58040934-3A61655B-1210-46B9-9C89-90BD30BC3087
P2860
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@ast
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@en
type
label
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@ast
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@en
prefLabel
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@ast
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@en
P2093
P2860
P921
P1476
Prevention of thromboembolism ...... ulants and antiplatelet drugs.
@en
P2093
K A Robinson
M R Miller
R L McNamara
S N Goodman
P2860
P356
10.1046/J.1525-1497.2000.04329.X
P577
2000-01-01T00:00:00Z
P5875
P6179
1043484442